Risk of antigen excess in serum free light chain measurements

被引：38

作者：

Daval, Sandrine

Tridon, Arlette

Mazeron, Nicole

Ristori, Jean-Michel

Evrard, Bertrand

机构：

[1] Hop Hotel Dieu, Dept Immunol, F-63058 Clermont Ferrand, France

[2] Univ Clermont Ferrand, Hop Hotel Dieu, Dept Immunol, Ctr Hosp, Clermont Ferrand, France

[3] Univ Clermont 1, Fac Med Pharm, Clermont Ferrand, France

[4] Univ Clermont Ferrand, G Montpied Hosp, Ctr Hosp, Dept Rheumatol, Clermont Ferrand, France

来源：

CLINICAL CHEMISTRY | 2007年 / 53卷 / 11期

关键词：

D O I：

10.1373/clinchem.2007.093377

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1985 / 1986

页数：2

共 5 条

[1]

Bradwell AR, 2001, CLIN CHEM, V47, P673

[2] Serum test for assessment of patients with Bence Jones myeloma [J].

Bradwell, AR ;

Carr-Smith, HD ;

Mead, GP ;

Harvey, TC ;

Drayson, MT .

LANCET, 2003, 361 (9356) :489-491

[3] Serum free light chains: An alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies [J].

Hill, Peter G. ;

Forsyth, Julia M. ;

Rai, Baldeep ;

Mayne, Stewart .

CLINICAL CHEMISTRY, 2006, 52 (09) :1743-1748

[4]

Katzmann JA, 2002, CLIN CHEM, V48, P1437

[5] Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance [J].

Rajkumar, SV ;

Kyle, RA ;

Therneau, TM ;

Melton, LJ ;

Bradwell, AR ;

Clark, RJ ;

Larson, DR ;

Plevak, MF ;

Dispenzieri, A ;

Katzmann, JA .

BLOOD, 2005, 106 (03) :812-817

← 1 →